In vivo studies on chiral inversion and amino acid conjugation of 2-[4- (3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs

Drug Metabolism and Disposition

Volumn 27, Issue 1, 1999, Pages 158-160

  Konishi, Tadao ^a   Nishikawa, Hitoshi ^a   Kitamura, Shigeyuki ^b   Tatsumi, Kiyoshi ^b  

^a Maruho Co   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (3 METHYL 2 THIENYL)PHENYL]PROPIONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; CHIRALITY; CONJUGATION; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONFORMATION; DRUG METABOLISM; DRUG URINE LEVEL; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOGS; MALE; PHENYLPROPIONATES; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; TAURINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0345561583     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adams SS, Bresloff P and Mason CG (1976) Pharmacological differences between the optical isomers of ibuprofen: Evidence for metabolic inversion of (-)-isomer. J Pharm Pharmacol 28:256-257.
2. Asami M, Takasaki W, Iwabuchi H, Haruyama H, Wachi K, Terada A and Tanaka Y (1995) Stereospecific taurine conjugation of the trans-OH metabolite (active metabolite) of CS-670. a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug, in dogs. Biol Pharm Bull 18:1584-1589.
3. Saillie TA, Adams WJ, Kaiser DG, Olanoff LS, Halstead GW, Harpootlian H and Glossen GJV (1989) Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J Pharmacol Exp Ther 249:517-523.
4. Buttinoni A, Ferrari M, Colombo M and Ceserani R (1983) Biological activity of indoprofen and its optical isorners. J Pharm Pharmacol 35:603-604.
5. Caldwell J, Hutt AJ and Fournel-Gigleux S (1988) The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem Phamacol 37:105-114.
6. Fournel S and Caldwell J (1986) The metabolic chiral inversion of 2-phenylprupionic acid in rat. mouse and rabbit. Biochem Pharmacol 35:4153-4159.
7. Gaul ZN, Baruth H, Randall LO, Ashley C and Paulsrud JR (1975) Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase. Prostaglandins 10:59-66.
8. Hutt AJ and Caldwell J (1990) Amino acid conjugation, in Cunjugation Reactions in Drug Metabolism (Mulder GJ ed) pp 273-305, Tayler & Francis Ltd. London.
9. Kalaoka M, Tonooka K, Ando T, Imai K and Aimoto T (1997) Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs. Free Rad Res 27:419-427.
10. Kean WF, Lock CJL, Rischke J, Butt R. Buchanan WW and Howard-Lock H (1989) Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets. J Pharm Sci 78:324-327.
11. Kido H, Murakami N, Ito A, Kimura K, Kodera N, Doi T and Naruse T (1998) Anti-inflammalory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new nonsteroidal anti-inflammatory drug, in rats and guinea pigs. Jpn J Pharmacol 76:75-86.
12. Konishi T, Okada S, Nishikawa H, Esumi Y, Kitamura S and Tatsumi K (1998a) Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys. Arzieim-Forsch/Drug Res 48:266-274.
13. Konishi T, Nishikawa H, Kitamura S and Tatsumi K (1998b) Stereoselective determination of R,S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and its taurine conjugates in dog urine by high-performance liquid Chromatography. J Chromatogr B 709:105-111.
14. Lee EJD, Williams K, Day R, Graham G and Champion D (1985) Stereoselective disposition of ibuprofen enantiomers in man. Br J Clin Pharmacol 19:669-674.
15. Mayer JM, Bartolucci C, Maitre J-M and Testa B (1988) Metabolic chiral inversion of anti-inflammatory 2-arylpropionates: Lack of reaction in liver homogenates, and study of methine proton acidity. Xenabiotica 18:533-543.
16. Muller N, Payan E, Lapicque F, Bannwarth B and Netter P (1990) Pharmacological aspects of chiral nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 4:617-634.
17. Murakami N, Takase H, Tomita T, Iwata K and Naruse T (1996) Antinociceptive activity of a novel non-steroidal anti-inflammatory drug (M-5011) with low ulcerogenic effects in mice. Jpn J Pharmacol 72:29-37.
18. Nakamura Y, Yamaguchi T, Takahashi S, Hashimoto S, Iwatani K and Nakagawa Y (1981) Optical isomerization mechanism of R(-)-hydratropic acid derivatives. J Pharmacobio-Dyn 4:S-1.
19. Shieh W-R and Chen C-S (1993) Purification and characterisation of novel "2-arylpropionyl-CoA epimerases" from liver cytosol and mitochondria. J Biol Chem 268:3487-3493.
20. Shirley MA, Guan X, Kaiser DG, Halstead GW and Baillie TA (1995) Taurine conjugation of ibuprofen in humans and in rat liver in vitro: Relationship to metabolic chiral inversion. J Pharmacol Exp Ther 269:1166-1175.
21. Tanaka Y, Shimonura Y, Hirota T, Nozaki A, Ebata M, Takasaka W, Shigehara E, Hayashi R and Caldwell J (1992) Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylpropionic acid suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer in dogs. Chirality 4:342-348.
22. Tobetto K, Yamamoto Y, Kataoka M, Ando T, Sugimoto K and Himeno M (1997) The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts. Jpn J Pharmacol 75:371-379.
23. Yamaguchi T and Nakamura Y (1987) Stereoselective metabolism of 2-phenylpropionic acid in rat. II. Studies on the organs responsible for the optical isomerization of 2-phenylpropionic acid in rat in vivo. Drug Metab Dispos 15:535-539.